NYXH announces U.S. ACCCESS pivotal study meets safety, efficacy endpoints
NYXOAH said its ACCCESS U.S. pivotal study met primary safety and efficacy endpoints in complete concentric collapse patients.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.